$1,320,000 of PHILLIPS 66 lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"*draft* legislation supporting year around E15 and Small Refinery Exemption reform; H.R. 7148 - Consolidated Appropriations Act, 2026 - Amendment #6; Renewable Fuels Standard RVO Annual Rule 2026 and 2027; Issues pertaining to EPA potentially granting small refinery exemptions; Issues arising from the Midwest governors petition to remove the 1-psi waiver and the related EPA rulemaking; FTZ designation application; H.R. 3109, REFINER Act; Executive actions related to emergency RVP waivers; S. 3759 and H.R. 6518, Securing Americas Fuels Act Standards of Performance for New, Reconstructed, and Modified Sources and Emissions Guidelines for Existing Sources: Oil and Natural Gas Sector Climate Review; OOOO b/c Reconsideration; *draft* Regulatory improvements to OOOO b/c; *draft* Subpart W reconsideration; Greenhouse Gas Reporting Rule: Revisions and Confidentiality Determinations for Petroleum and Natural Gas Systems; Reforms to Toxic Substances Control Act and the nomenclature process IRC code sections 168(k) and 45Z and 45Q; Section 45Z Clean Fuel Production Credit Guidance Draft legislation to reauthorize PHMSA; S. 2975, Pipeline Safety Act of 2025; H.R. 5301, PIPES Act; *draft* permitting reform legislation; Support for proposed infrastructure projects; H.R. 3898, the Promoting Efficient Review for Modern Infrastructure Today (PERMIT) Act; H.R. 4776, SPEED Act Section 301 Investigation of Chinas Targeting of the Maritime, Logistics, and Shipbuilding Sectors for Dominance; Issues related to exporting renewable fuels to Europe; Support for US energy products in US trade agreements; Support for USMCA; Executive actions pertaining to Jones Act waivers; Executive actions relating to fuel price mitigation; GENERAL LICENSE NO. 129A Authorizing Transactions Involving Rosneft Deutschland GmbH and RN Refining & Marketing GmbH; General advocacy to support market access in Latin America"
You can find more data on corporate lobbying on Quiver Quantitative.
PSX Insider Trading Activity
PSX insiders have traded $PSX stock on the open market 13 times in the past 6 months. Of those trades, 1 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $PSX stock by insiders over the last 6 months:
- BRIAN MANDELL (Executive Vice President) has made 0 purchases and 4 sales selling 94,500 shares for an estimated $14,433,940.
- KEVIN J MITCHELL (Exec. VP and CFO) has made 0 purchases and 4 sales selling 67,429 shares for an estimated $10,762,013.
- VANESSA ALLEN SUTHERLAND (EVP, GC and Secretary) has made 0 purchases and 2 sales selling 8,788 shares for an estimated $1,296,230.
- DON BALDRIDGE (Executive Vice President) sold 7,500 shares for an estimated $1,200,000
- LISA ANN DAVIS sold 3,800 shares for an estimated $662,617
- KEVIN OMAR MEYERS purchased 175 shares for an estimated $30,309
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PSX Hedge Fund Activity
We have seen 846 institutional investors add shares of PSX stock to their portfolio, and 787 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,326,628 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $945,428,077
- M&T BANK CORP added 2,243,268 shares (+462.9%) to their portfolio in Q4 2025, for an estimated $289,471,302
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 2,131,878 shares (-67.7%) from their portfolio in Q4 2025, for an estimated $275,097,537
- BANK OF NEW YORK MELLON CORP removed 1,410,831 shares (-16.6%) from their portfolio in Q4 2025, for an estimated $182,053,632
- AQR CAPITAL MANAGEMENT LLC added 1,369,287 shares (+72.3%) to their portfolio in Q4 2025, for an estimated $176,692,794
- UBS GROUP AG removed 1,348,908 shares (-30.4%) from their portfolio in Q4 2025, for an estimated $174,063,088
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,225,109 shares (-22.5%) from their portfolio in Q4 2025, for an estimated $158,088,065
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PSX Analyst Ratings
Wall Street analysts have issued reports on $PSX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Freedom Capital Markets issued a "Sell" rating on 01/06/2026
- UBS issued a "Buy" rating on 11/03/2025
- Wells Fargo issued a "Overweight" rating on 10/30/2025
- TD Cowen issued a "Buy" rating on 10/30/2025
To track analyst ratings and price targets for PSX, check out Quiver Quantitative's $PSX forecast page.
PSX Price Targets
Multiple analysts have issued price targets for $PSX recently. We have seen 12 analysts offer price targets for $PSX in the last 6 months, with a median target of $177.0.
Here are some recent targets:
- Vikram Bagri from Citigroup set a target price of $183.0 on 04/09/2026
- Theresa Chen from Barclays set a target price of $177.0 on 04/08/2026
- Ryan Todd from Piper Sandler set a target price of $177.0 on 04/08/2026
- Manav Gupta from UBS set a target price of $212.0 on 04/02/2026
- Sam Margolin from Wells Fargo set a target price of $201.0 on 03/31/2026
- Justin Jenkins from Raymond James set a target price of $205.0 on 03/25/2026
- Nitin Kumar from Mizuho set a target price of $170.0 on 03/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
